Cargando…
Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung
The lung is the vital target organ of coronavirus disease 2019 (COVID-19) caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the majority of patients the most active virus replication seems to be found in the upper respiratory tract, severe cases however suffer...
Autores principales: | Förster, Reinhold, Fleige, Henrike, Sutter, Gerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426738/ https://www.ncbi.nlm.nih.gov/pubmed/32849655 http://dx.doi.org/10.3389/fimmu.2020.01959 |
Ejemplares similares
-
IL-1β Promotes Staphylococcus aureus Biofilms on Implants in vivo
por: Gutierrez Jauregui, Rodrigo, et al.
Publicado: (2019) -
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
por: Bošnjak, Berislav, et al.
Publicado: (2021) -
Sequestration of Late Antigens Within Viral Factories Impairs MVA Vector-Induced Protective Memory CTL Responses
por: Tao, Sha, et al.
Publicado: (2019) -
The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice
por: Do, Kim Thi Hoang, et al.
Publicado: (2023) -
IL-17–induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs
por: Fleige, Henrike, et al.
Publicado: (2014)